-
de Vries S, Krul I, Schaapveld M, Janus CMP, et al.
Risk of male breast cancer after Hodgkin lymphoma. Blood 2023.
-
Huber S, Baer C, Hutter S, Dicker F, et al.
AML classification in the year 2023: How to avoid a Babylonian confusion of
languages. Leukemia 2023;37:1413-1420.
-
Aroda VR, Aberle J, Bardtrum L, Christiansen E, et al.
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with
14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised,
phase 3b trial. Lancet 2023.
-
Kurian AW, Abrahamse P, Furgal A, Ward KC, et al.
Germline Genetic Testing After Cancer Diagnosis. JAMA 2023;330:43-51.
-
Chow R, Hasan S, Choi JI, Fox J, et al.
Effect of Treatment Interruptions on Overall Survival in Patients with Triple
Negative Breast Cancer. J Natl Cancer Inst 2023.
|